4-Defluoro dolutegravir is an impurity of the active pharmaceutical ingredient dolutegravir, structurally characterized as a tricyclic compound containing fluorine and multiple heterocyclic rings. It is primarily encountered as a reference standard or process-related impurity during the manufacturing and quality control of dolutegravir.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1863916-87-3
Dolutegravir
pharmaceutical raw material
2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4S,12aR)-
pharmaceutical raw material
4-epi-Dolutegravir
pharmaceutical raw material
Capmatinib dihydrochloride monohydrate
pharmaceutical raw material
(RS)-ketamine hydrochloride
pharmaceutical raw material
Abiraterone Acetate 5,6-Epoxide
pharmaceutical raw material
(3S,4aS,5aR,6aS,6bS,9aS,11aS,11bR)-9a,11b-dimethyl-9-(pyridin-3-yl)-1,2,3,4,5a,6,6a,6b,7,9a,10,11,11a,11b-tetradecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-3-yl acetate
pharmaceutical raw material
Dolutegravir sodium
pharmaceutical raw material
(3S,7R)-N-[(2-fluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
XBOHLWYCZARIPT-ABAIWWIYSA-N
C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=CC=CC=C4F)O